Related Experiment Videos
Taurine-diabetes interaction: from involvement to protection
1Department of Pharmacology, Metabolic Diseases Research Laboratory, School of Dentistry, Kyung Hee University, Seoul, Korea. kimsj@khu.ac.kr
Journal of Biological Regulators and Homeostatic Agents
|February 12, 2008
Summary
Taurine, a sulfur amino acid, shows promise in managing diabetes and its complications. Its potential role in preventing diabetes transmission and developing new therapeutic analogs warrants further investigation.
Area of Science:
- Biochemistry
- Endocrinology
- Pharmacology
Background:
- Taurine (2-amino ethane sulfonic acid) is a sulfur amino acid with diverse physiological roles.
- Taurine is implicated in the regulation of insulin secretion and function, suggesting a role in glucose homeostasis.
- Existing diabetes therapies like sulfonylureas and thiazolidinediones have limitations and complications.
Purpose of the Study:
- To review the multifaceted roles of taurine in diabetes mellitus.
- To explore taurine's potential in preventing diabetes and its complications.
- To consider taurine derivatives as novel therapeutic agents for diabetes.
Main Methods:
- Literature review of studies on taurine and diabetes.
- Analysis of taurine's biochemical mechanisms of action.
- Evaluation of clinical evidence for taurine supplementation in diabetic complications.
Main Results:
- Taurine exhibits hypoglycemic properties and beneficial effects on diabetic complications such as neuropathy, cardiomyopathy, and retinopathy.
- Taurine plays a role in protecting the insulin apparatus and may block mother-to-offspring diabetes transmission.
- Proposed mechanisms include osmoregulation and anti-oxidation.
Conclusions:
- Taurine demonstrates significant potential in managing diabetes and its associated pathologies.
- The development of taurine analogues presents a promising avenue for alternative diabetes therapeutics.
- Further research into taurine's role in diabetes prevention and treatment is warranted.
Related Concept Videos
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...